How to choose a ventilator

A procurement guide for ICU directors, biomedical engineers, and capital-equipment teams navigating a market where device selection has direct downstream effects on patient outcomes and per-day care costs.

What this is and who buys it

Mechanical ventilators deliver positive-pressure breaths to patients who cannot breathe adequately on their own — covering everything from short-term post-surgical support in the OR to months-long weaning in a long-term acute-care hospital (LTACH). They are among the most consequential capital purchases a facility makes: mechanical ventilation adds roughly $1,522 per day to the mean incremental cost of an ICU stay [S6, S7], which means a poorly matched platform can affect length-of-stay metrics and ventilator-associated event (VAE) rates in ways that show up directly on the CFO's dashboard.

Buyers span a wide range of clinical settings. ICU medical directors and respiratory therapy leadership typically drive the clinical specification, while biomedical engineering evaluates maintainability and calibration demands, and procurement negotiates price and service-contract terms. The purchase cycle is usually tied to a multi-year capital plan, a major ICU build-out, or fleet standardization — though the COVID-19 pandemic pushed many systems into rapid, unplanned procurement that exposed the risks of mismatched device indications and inadequate acceptance testing.

It is worth establishing at the outset that "ventilator" is not a single product category. Critical-care ICU platforms, transport units, anesthesia workstations, home-care vents, and neonatal high-frequency oscillators each operate under different regulatory frameworks and consensus standards. Treating them interchangeably is one of the most common and consequential procurement errors in this space.

Key decision factors

Patient population and care environment are the first — and non-negotiable — starting point. The FDA requires that a 510(k) submission specifically state the intended environment of use and the patient population (adult, pediatric, infant, neonate) for which a ventilator is cleared [S5]. That cleared indication must match your actual case mix. A platform cleared only for adult sub-acute use cannot be deployed as a primary ICU vent for neonates without stepping outside its regulatory envelope, regardless of what a sales representative implies.

Ventilation modes and lung-protective tools matter because ICU practice has shifted decisively toward adaptive, lung-protective strategies. Volume control, pressure control, PRVC, SIMV, PSV, and NIV are table stakes; differentiation comes from adaptive modes such as ASV, APRV, and PAV/NAVA. On the bench, demand PEEP accuracy within ±1 cmH₂O at 5, 10, and 15 cmH₂O, and peak inspiratory pressure transducer accuracy within ±2 cmH₂O [S5]. Tidal-volume accuracy of ±10% is the accepted floor.

Gas source — turbine versus pneumatic is a decision that follows directly from your infrastructure. Turbine/blower-driven units draw ambient air internally and operate without a 50-psi wall gas supply, making them viable for transport, MRI suites, and surge deployment in non-piped spaces. Pneumatic units typically offer superior flow fidelity at high clinical demand but are tethered to medical-gas infrastructure. Confirm the internal compressor's altitude and temperature performance envelope if your facility sits above 5,000 feet or operates in extreme heat.

Monitoring and graphics depth directly support weaning and lung-protection protocols. Esophageal pressure (Pes), transpulmonary pressure, P0.1, work-of-breathing, and volumetric capnography are no longer exotic add-ons in a serious ICU context — they drive daily clinical decisions on PEEP titration and extubation readiness. Evaluate whether these capabilities are native to the platform or require costly third-party modules.

Alarm architecture and connectivity deserve more scrutiny than they typically receive. Alarm compliance with IEC 60601-1-8 is the minimum baseline [S10]. Beyond that, verify HL7 or FHIR integration with your EMR, central-station alarm forwarding, and — critically — the vendor's cybersecurity posture: network segmentation support, OS patching cadence, and availability of a software bill of materials (SBOM). Networked ventilators transmit protected health information and must be managed accordingly under HIPAA.

Battery runtime and consumables economics close out the technical picture. Internal Li-ion batteries typically